Capital Research Global Investors Eli Lilly & CO Transaction History
Capital Research Global Investors
- $463 Billion
- Q3 2024
A detailed history of Capital Research Global Investors transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital Research Global Investors holds 9,263,838 shares of LLY stock, worth $7.11 Billion. This represents 1.77% of its overall portfolio holdings.
Number of Shares
9,263,838
Previous 9,119,534
1.58%
Holding current value
$7.11 Billion
Previous $8.26 Billion
0.6%
% of portfolio
1.77%
Previous 1.86%
Shares
10 transactions
Others Institutions Holding LLY
# of Institutions
4,011Shares Held
751MCall Options Held
8.27MPut Options Held
10.5M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$74.4 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.8MShares$56.6 Billion1.2% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$50.6 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$39.4 Billion29.2% of portfolio
-
State Street Corp Boston, MA33.9MShares$26 Billion1.24% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $730B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...